Stocksigma LogoStocksigma Logo

Gujarat Kidney & Superspeciality Reports Q2'27 IPO Funds Utilization and Approved Object Variations

Gujarat Kidney and Superspeciality Limited reported its IPO proceeds utilization for the quarter ended 30th Sep'26, following its ₹250.80 Cr public issue

Gujarat Kidney & Superspeciality Reports Q2'27 IPO Funds Utilization and Approved Object Variations

Gujarat Kidney and Super Speciality Ltd · Others (Uncategorized) · 05 Nov 2026, 1:44 am

Gujarat Kidney & Superspeciality Reports Q2'27 IPO Funds Utilization and Approved Object Variations Gujarat Kidney and Superspeciality Limited reported its IPO proceeds utilization for the quarter ended 30th Sep'26, following its ₹250.80 Cr public issue raised on 24th Dec'25. Shareholders approved object variations via Postal Ballot on 22nd Aug'26, reallocating Vadodara capex funds toward broader healthcare expansion (₹17.92 Cr) and acquiring a 51% stake in Blue Tree Clinics LLC, Dubai (₹7.23 Cr), alongside repurposing robotics capex (₹6.83 Cr) for dialysis services. As of 1st Oct'26, unutilized IPO proceeds stand at ₹18.34 Cr.

Original exchange filing (PDF)

More announcements from Gujarat Kidney and Super Speciality Ltd

All Gujarat Kidney and Super Speciality Ltd announcements